BioSpace News Archive

Wilmington, Delaware, United States, Transparency Market Research Inc. – The global injectable drugs market is relied upon to enlist a strong double-digit CAGR within the forecast period from 2019 to 2027.

The kidney transplant market has been projected to grow at a noteworthy speed in the foreseeable years.

The rising cases of hospital-acquired infections are a prime factor boosting the global infection surveillance solutions market.

The radiation oncology market is expected to observe immense opportunities across the assessment period of 2020-2030.

The inhaled nitric oxide delivery systems market is estimated to grow at a significant speed in the upcoming years.

The automated and closed cell therapy processing systems market is predicted to grow at a noteworthy speed in the upcoming years

Immune Therapeutics, Inc., a pioneering pharmaceutical company involved in the acquisition, development, and commercialization of pharmaceutical and biotechnology products that have a short and well-defined path to market, is pleased to announce it is in full compliance with OTC Markets following the filing of its 10-Q allowing removal of the delinquency flag and a return to Current Information status with the OTC Markets Group.

Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) announced today development of a novel immunotherapy for treatment of solid tumors. Current cellular approaches to kill cancer involve administration of a specific type of modified T cell called “chimeric antigen receptor” (CAR) T cell.

ŌNŌCOR LLC announced the use of the ŌNŌ endovascular retrieval system to remove a large central-line-associated thrombus from the right atrium in a teenage patient.

MDxHealth SA, a commercial-stage precision diagnostics company, announced its financial results for the half year ended June 30, 2022.